Following a negative FDA advisory committee vote earlier this year, the other shoe has dropped for Lundbeck and Otsuka ...

With a Sept. 29 deadline looming for pharmaceutical companies to adhere to President Donald Trump’s Most Favored Nation drug ...

As Halloween approaches, Exact Sciences is warding off a particularly terrifying occurrence: skipping colorectal cancer ...

With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...

AI is now the first place people go to for answers,” according to Jesse Wolfersberger, global lead of I/O Health at Weber ...

Stealth’s injection, known as elamipretide, will be sold as Forzinity for the treatment of Barth syndrome, an X-linked ...

While the test was conducted in NSCLC, the FDA approval includes existing solid tumor indications for Keytruda. Merck is running a separate pivotal study in previously treated Hodgkin lymphoma and ...

After reaching the summit in a yearslong mission of introducing Takeda’s plasma-derived therapies (PDTs) to the market in its home country of Japan, Takeda team members started mapping out their ne | ...

Separately, the ACIP members reversed their vote on a recommendation they’d shot down Thursday pertaining to coverage of ...

The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences ...

Eli Lilly has been censured by the U.K. marketing watchdog after a complainant reported being hit by a “bombardment of spam.” ...

Trust in pharma has always been fragile, and the rise of misinformation has made it even more precarious. | Freda Lewis-Hall, ...